Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
4(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
63%
Ph early_phase_1
2
25%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
2(28.6%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Completed(2)
Other(1)

Detailed Status

Recruiting3
Completed2
Not yet recruiting1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
4
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 12 (28.6%)
N/A5 (71.4%)

Trials by Status

not_yet_recruiting113%
recruiting338%
completed225%
active_not_recruiting113%
unknown113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8